Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder

A Open-label, Long-term Extension Study of KUC-7483 in Patients With Overactive Bladder

To investigate the long-term safety, efficacy and pharmacokinetics of KUC-7483 in patients with overactive bladder.

Inclusion Criteria:

• Patients who have successfully completed the Phase III double-blind study.

Exclusion Criteria:

• Patients with serious adverse events or clinically significant adverse events in the Phase III double-blind study.